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Contrast enhanced ultrasound (CEUS) has been 
used previously to demonstrate perfusion at the 
tissue level1. These contrast agents consist of 
perfluorocarbon gas surrounded by a lipid shell, 
and can be bound to antibodies for cell-surface 
proteins in order to provide sustained image 
enhancement where these proteins are expressed 
by vascular endothelial cells1. Several studies have 
utilized targeted CEUS to investigate angiogenesis 
in tumors2. The use of targeted CEUS with an 
affinity for P-selectin, a protein expressed on the 
surface of endothelial cells during inflammation, 
could allow for the detection of inflammatory 
processes at a cellular level, potentially offering an 
earlier diagnosis of neural inflammation3. 
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Figure 1. Diagram of experimental intervention 
which induces neural inflammation. 
Mice were imaged seven days after receiving a 
laminectomy and traumatic spinal cord injury at the 
T9 level. Sagittal images of the spinal cord at the 
T9 level were collected with a Vevo 2100 unit 
equipped with a 40 MHz transducer. While imaging 
continuously, contrast microbubbles bound with 
anti-P-selectin antibodies were injected via the tail 
vein and allowed to circulate for 10 minutes, at 
which point a bursting mechanism was activated 
on the ultrasound unit, rupturing all microbubbles 
within the beam profile4. The imaging procedure 
was repeated using ultrasound contrast bound to 
an isotype control antibody, which exhibits minimal 
binding interactions with cell surface antigens. 
Images from before and after the bursting pulse 
were processed using analysis software. By 
comparing the greyscale ultrasound images to a 
reference set of images taken before the contrast 
injection, the software generated a colored overlay 
of contrast distribution. A region of interest (ROI) 
was traced around the T9 spinal cord segment, 
which allowed for graphs to be generated, showing 
the variation in contrast signal amplitude in this 
region during the 10 minute scanning period. 
Figure 2. Sagittal images of the spinal cord, demonstrating accumulation of anti-
P-selectin targeted contrast (A) before and (B) after the bursting pulse. 
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In the control contrast scan, the signal amplitude 
dropped quickly after peaking (Graph 1), while the 
contrast bound to anti-P-selectin showed a 
sustained peak and more gradual reduction in 
amplitude (Graph 2), This result is indicative of 
contrast binding. Trend graphs from mice injected 
with contrast bound to the isotype control antibody 
showed a stable signal amplitude after 10 minutes, 
with no significant reduction in amplitude after the 
bursting pulse (Graph 3). Trend graphs from mice 
injected with contrast bound to anti-P-selectin 
showed a significant decrease in signal amplitude 
following the bursting pulse (Graph 4). With any 
background tissue signal removed during image 
processing, the contrast signal amplitude is 
considered to be the sum of the signals from 
contrast bound to P-selectin and from circulating, 
unbound contrast2. The bursting pulse destroys all 
contrast microbubbles within the ultrasound beam 
profile, eliminating any bound bubbles, with a 
minimal reduction in circulating contrast4. Where 
binding occurs, a drop in the amplitude can be 
seen after the burst, due to the elimination of 
bound microbubbles (Graph 4). If no bubbles are 
binding, no drop in amplitude will occur, since the 
amount of bubbles in circulation is essentially 
unchanged (Graph 3). Results consistent with this 
explanation suggest that the anti-P-selectin 
targeted microbubbles were bound to expressed P-
selectin in the inflamed neural tissue at T9. 
This pilot study successfully demonstrated the 
ability of targeted CEUS to detect inflammatory 
markers in neural tissue. CEUS targeting of 
inflammatory markers has been accomplished in 
other soft tissues with microbubbles targeted to P-, 
L-, E-selectin, VCAM-1, and ICAM-15. Following 
the protocol of this experiment, these efforts should 
be replicated in neural tissue, with a larger cohort, 
in order to determine which markers allow the most 
sensitive detection of neural inflammation. The 
inclusion of 3D contrast ultrasound imaging in 
future studies may offer a better understanding of 
global perfusion and inflammatory processes in the 
spinal cord beyond the site of injury. 
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